RAISEing VEGF-D's importance as predictive biomarker for ramucirumab in metastatic colorectal cancer patients

Ann Oncol. 2018 Mar 1;29(3):527-529. doi: 10.1093/annonc/mdy028.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antibodies, Monoclonal*
  • Antibodies, Monoclonal, Humanized
  • Biomarkers
  • Double-Blind Method
  • Humans
  • Vascular Endothelial Growth Factor D*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Biomarkers
  • Vascular Endothelial Growth Factor D
  • ramucirumab